Chongqing Lummy Pharmaceutical Co Ltd: A Pillar in China’s Pharmaceutical Landscape
In the bustling city of Chongqing, a company has been making significant strides in the pharmaceutical industry since its inception in 1999. Chongqing Lummy Pharmaceutical Co., Ltd., a key player in China’s healthcare sector, has been dedicated to advancing medical science through its comprehensive range of pharmaceutical products. With its headquarters firmly rooted in Chongqing, the company has carved out a niche for itself on the Shenzhen Stock Exchange, showcasing its robust financial health and commitment to innovation.
As of July 24, 2025, Chongqing Lummy Pharmaceutical’s stock closed at 5 CNY, reflecting a dynamic journey through the fiscal year. The company’s stock has experienced fluctuations, reaching a 52-week high of 6.43 CNY on December 11, 2024, and a low of 2.36 CNY on July 29, 2024. Despite these variations, the company’s market capitalization stands impressively at 5,184,522,731 CNY, underscoring its substantial presence in the pharmaceutical industry.
Chongqing Lummy Pharmaceutical’s portfolio is as diverse as it is impactful. The company is at the forefront of developing and manufacturing a wide array of pharmaceutical products. These include critical medications for tumor treatment, antibacterial, antiviral, and antifungal therapies, as well as drugs for liver disease and endocrinology systems. Additionally, the company produces Chinese patent drugs, catering to various health needs such as digestive, immune, blood, cardiovascular, and nervous system disorders.
Beyond these, Chongqing Lummy Pharmaceutical is also known for its acid-base balance and nutritional products, base large infusion products, American ginseng systems, and active pharmaceutical ingredients. This extensive range highlights the company’s dedication to addressing a broad spectrum of health concerns, reinforcing its role as a vital contributor to public health in China and beyond.
The company’s commitment to research and development is a cornerstone of its success. By continuously investing in innovation, Chongqing Lummy Pharmaceutical ensures that it remains at the cutting edge of medical science, providing effective and reliable solutions to some of the most pressing health challenges of our time.
As Chongqing Lummy Pharmaceutical Co., Ltd. continues to grow and evolve, its impact on the pharmaceutical industry and global health landscape is undeniable. With a strong foundation in research, development, and manufacturing, the company is well-positioned to lead the way in healthcare innovation, making a lasting difference in the lives of people around the world.